As this week’s political woes endure, it appears investors are still more concerned with the economy and corporate earnings, rather than President Trump’s legal issues. Although equities have slightly dropped, for the most part, they are still standing strong.
The S&P 500 ETF (SPY) closed the day 0.1% lower on Thursday after changing between small gains and losses, while the Dow Jones Industrial Average ETF (DIA) took in a small loss as well. Equities also gave up early gains to close the day somewhat lower, leaving the S&P 500 (SPY) just 0.5% away from Tuesday’s all-time high.
Since the current bull market has now become longest in history, investors are seeking new opportunities within the market. Biotech stocks have come back into focus and the iShares Biotechnology ETF (IBB) is looking like it may be primed for its next leg up, trading just below all-time highs.
Biotech Stocks That Hit Fresh All-Time Highs Yesterday, August 23, 2018:
- Abbott Laboratories (ABT)
- Avanos Medical Inc (AVNS)
- BIO-TECHNE Corp (TECH)
- CareDx Inc (CDNA)
- DexCom, Inc. (DXCM)
- Emergent Biosolutions Inc (EBS)
- Myriad Genetics, Inc. (MYGN)
- Neogen Corporation (NEOG)
- Novocure Ltd (NVCR)
- Repligen Corporation (RGEN)
- SurModics, Inc. (SRDX)
- Tandem Diabetes Care Inc (TNDM)
- Xeris Pharmaceuticals Inc (XERS)
As the biotech sector continues to heat up, here are a few biotech stocks for investors to consider adding to their portfolios.